Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mary Aghoghovbia"'
Autor:
Aby Buchbinder, Florence Hourcade-Potelleret, Tycho Heimbach, Handan He, Xianbin Tian, Mary Aghoghovbia, Hefei Zhang
Publikováno v:
The Journal of Clinical Pharmacology. 58:1533-1540
Nilotinib, an oral inhibitor of the tyrosine kinase activity of Abelson protein, is approved for the treatment of patients with newly diagnosed chronic myeloid leukemia (CML) in chronic phase and patients with CML in chronic phase or accelerated phas